Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michele Johnson-Towson

Pediatrics Tampa, FL Medical Doctor

NPI 1659431484 CMS profile 166166

1338 W Fletcher Ave, Tampa, FL 33612

Open in the dashboard

General payments

$9,525

170 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$40,237 paid to institutions, not to them · program year 2025

Through program year 2025, Michele Johnson-Towson of Tampa, FL is reported in the CMS Open Payments database as having received $9,525 across 170 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $40,237 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,931 18
2024 General $660 21
2023 General $338 18
2022 General $261 18
2021 General $2,519 55
2020 General $265 14
2019 General $551 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michele Johnson-Towson
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Michele Johnson-Towson were reported at $4,931. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Michele Johnson-Towson Pediatrics median Middle half National median
2019 $551 $86 $31–$183 $163
2020 $265 $49 $22–$110 $114
2021 $2,519 $68 $27–$158 $132
2022 $261 $77 $30–$173 $149
2023 $338 $88 $33–$190 $160
2024 $660 $94 $34–$206 $164
2025 $4,931 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. ALK-Abello, Inc $4,788 15 payments
  2. Welch Allyn $1,852 1 payment
  3. Sobi, Inc $650 37 payments
  4. Pfizer Inc. $596 36 payments
  5. Supernus Pharmaceuticals, Inc. $308 25 payments
  6. GlaxoSmithKline, LLC. $249 10 payments
  7. Merck Sharp & Dohme Corporation $173 10 payments
  8. Cranial Technologies, Inc $167 9 payments
  9. Sanofi Pasteur Inc. $139 7 payments
  10. Tris Pharma Inc $112 1 payment
  11. Other $489 19 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Honoraria $3,320 1 payment
  2. Food and Beverage $3,193 166 payments
  3. Long term medical supply or device loan $1,852 1 payment
  4. Travel and Lodging $1,160 2 payments
Products named General payments · program years 2019–2025
  1. Odactra $4,788 15 payments
  2. Suresight Vision Screener $1,852 1 payment
  3. SYNAGIS $650 37 payments
  4. EUCRISA $473 29 payments
  5. Grastek $308 12 payments
  6. BEXSERO $221 8 payments
  7. Qelbree $184 4 payments
  8. GARDASIL 9 $173 10 payments
  9. Doc Band $167 9 payments
  10. Ragwitek $139 7 payments
  11. Other $2,247 111 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

170 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record